BEEF TALLOW DIET DECREASES BETA-ADRENERGIC-RECEPTOR BINDING AND LIPOLYTIC-ACTIVITIES IN DIFFERENT ADIPOSE TISSUES OF RAT

被引:30
作者
MATSUO, T [1 ]
SUMIDA, H [1 ]
SUZUKI, M [1 ]
机构
[1] UNIV TSUKUBA, INST HLTH & SPORT SCI, TSUKUBA, IBARAKI 305, JAPAN
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1995年 / 44卷 / 10期
关键词
D O I
10.1016/0026-0495(95)90028-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of dietary fats consisting of different fatty acids on lipolytic activity and body fat accumulation were studied in rats. Sprague-Dawley male rats were meal-fed an isoenergetic diet based on either beef tallow or safflower oil for 8 weeks. Lipolytic activities in epididymal and subcutaneous adipose tissues were lower in the beef tallow diet group than in the safflower oil diet group. Body fat accumulation was greater in rats fed the beef tallow diet versus the safflower oil diet. Norepinephrine (NE) turnover rates used as an index of sympathetic activities in adipose tissues were lower in the beef tallow diet group. beta-Adrenergic receptor binding was determined with [H-3]dihydroalprenolol. Binding affinities of beta-receptors adipose tissues were significantly lower in the beef tallow diet group. Membrane fluidities of adipose tissues were also lower in the beef tallow diet group. Membrane fluidities were correlated with the affinities of the beta-receptor. We believe from these correlations that the decreases in beta-receptor binding affinities are due to the changes in membrane fluidities. The results of the present study suggest that intake of the beef tallow diet promotes body fat accumulation by reducing lipolytic activities resulting from lower beta-receptor binding and sympathetic activity in adipose tissues.
引用
收藏
页码:1271 / 1277
页数:7
相关论文
共 33 条
[1]  
ALBERTS B, 1989, MOL BIOL CELL, P682
[2]  
ANDERSON DB, 1972, J LIPID RES, V13, P593
[3]   EFFECTS OF DIETARY LINOLENATE ON THE FATTY-ACID COMPOSITION OF BRAIN LIPIDS IN RATS [J].
ANDING, RH ;
HWANG, DH .
LIPIDS, 1986, 21 (11) :697-701
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]  
BRODIE BB, 1966, J PHARMACOL EXP THER, V154, P493
[6]  
BYLUND DB, 1976, MOL PHARMACOL, V12, P568
[7]  
Eggstein M., 1974, METHOD ENZYMAT AN, V4, P1825
[8]  
FOLCH J, 1957, J BIOL CHEM, V226, P497
[9]  
HILL JO, 1992, INT J OBESITY, V16, P321
[10]  
HOOD RL, 1977, J LIPID RES, V18, P275